Доступ предоставлен для: Guest
Портал Begell Электронная Бибилиотека e-Книги Журналы Справочники и Сборники статей Коллекции
Critical Reviews™ in Oncogenesis
SJR: 0.631 SNIP: 0.503 CiteScore™: 2

ISSN Печать: 0893-9675
ISSN Онлайн: 2162-6448

Critical Reviews™ in Oncogenesis

DOI: 10.1615/CritRevOncog.2016016120
pages 125-139

Circulating Tumor Cells in Breast Cancer Patients

Carolyn Hall
The University of Texas M.D. Anderson Cancer Center, Department of Surgical Oncology, Houston, Texas
Lily Valad
The University of Texas M.D. Anderson Cancer Center, Department of Surgical Oncology, Houston, Texas
Anthony Lucci
The University of Texas M.D. Anderson Cancer Center, Department of Surgical Oncology, Houston, Texas

Краткое описание

Breast cancer is the most commonly diagnosed cancer among women, resulting in an estimated 40,000 deaths in 2014.1 Metastasis, a complex, multi-step process, remains the primary cause of death for these patients. Although the mechanisms involved in metastasis have not been fully elucidated, considerable evidence suggests that metastatic spread is mediated by rare cells within the heterogeneous primary tumor that acquire the ability to invade into the bloodstream. In the bloodstream, they can travel to distant sites, sometimes remaining undetected and in a quiescent state for an extended period of time before they establish distant metastases in the bone, lung, liver, or brain. These occult micrometastatic cells (circulating tumor cells, CTCs) are rare, yet their prognostic significance has been demonstrated in both metastatic and non-metastatic breast cancer patients. Because repeated tumor tissue collection is typically not feasible and peripheral blood draws are minimally invasive, serial CTC enumeration might provide "real-time liquid biopsy" snapshots that could be used to identify early-stage breast cancer patients with micrometastatic disease who are at risk for disease progression and monitor treatment response in patients with advanced disease. In addition, characterizing CTCs might aid in the development of novel, personalized therapies aimed at eliminating micrometastases. This review describes current CTC isolation, detection, and characterization strategies in operable breast cancer.

Ключевые слова: circulating tumor cells, breast cancer

Articles with similar content:

Liquid Biopsies for Assessing Metastatic Melanoma Progression
Critical Reviews™ in Oncogenesis, Vol.21, 2016, issue 1-2
Dave S.B. Hoon, Kelly Huynh
Raf Kinase Inhibitory Protein (RKIP) as a Metastasis Suppressor: Regulation of Signaling Networks in Cancer
Critical Reviews™ in Oncogenesis, Vol.19, 2014, issue 6
Marsha Rich Rosner, Ali E. Yesilkanal
Targeting the Insulin-like Growth Factor Receptor: Developing Biomarkers from Gene Expression Profiling
Critical Reviews™ in Oncogenesis, Vol.17, 2012, issue 2
David N. Boone, Adrian V. Lee
Atopic Dermatitis: Drug Delivery Approaches in Disease Management
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.32, 2015, issue 4
Jitendra Baweja, Manisha Lalan, Ambikanandan Misra
Copine 3 as a Novel Potential Drug Target for Non-Small-Cell Lung Carcinoma
Journal of Environmental Pathology, Toxicology and Oncology, Vol.36, 2017, issue 2
Kunnathur Murugesan Sakthivel , Venugopal Vinod Prabhu